The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF 12th Spring Conference 2021

Current and Future Challenges of Innovative Oncology Drugs Development

Noordwijk aan Zee, Netherlands – 8-10 February 2021




The Cancer Drug Development Forum (CDDF) Spring conference 2021 is a unique forum that convenes every year and gathers the leaders in the world of innovative cancer therapy development, including medical researchers, pharmaceutical industry representatives, regulatory authority representatives and patient advocacy groups. It is the successor of the former CDDF Alpine Conference and the 12th edition takes place from 8 to 10 February 2021, in the Netherlands. 

This multi-stakeholder, interactive meeting offers plenary lectures with moderated discussions, including case studies and networking opportunities. The programme focuses on the latest and future challenges of Innovative oncology drugs development with a special emphasis on patient access, cancer drug development in a global setting, advances in imaging and regulatory guidance on oncology drug development.



  • Jaap Verweij (CDDF Board, NL)
  • Irmela Radtke (Roche, CH)
  • Ralf Herold (European Medicines Agency, NL)
  • Paul Stockman (AstraZeneca, UK)
  • Judith Taylor (Thyroid Cancer Alliance, Member of WECAN, UK)


The target is a multidisciplinary audience of academia representatives, EU and US regulatory bodies (EMA, FDA, National Agencies), pharmaceutical Industry, HTAs and patient advocates.



  • View the draft programme HERE



Radisson Blu Palace, Noordwijk aan zee (NL)

Address: Pickeplein 8, 2202 CL Noordwijk, Netherlands
Phone: +31 71 365 3000



Registration will be open soon.


Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70